- Trials with a EudraCT protocol (534)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
534 result(s) found for: Exploratory surgery.
Displaying page 1 of 27.
EudraCT Number: 2014-004610-29 | Sponsor Protocol Number: 2014.001 | Start Date*: 2015-02-18 |
Sponsor Name:Skanes University Hospital | ||
Full Title: Ciclosporin to Protect Renal function In Cardiac Surgery. CiPRICS. A Phase II Double Blind Randomized Placebo Controlled Study. | ||
Medical condition: Renal dysfunction after CABG surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-003416-38 | Sponsor Protocol Number: TMP-0916_02 | Start Date*: 2018-04-05 | |||||||||||
Sponsor Name:Fraunhofer Gesellschaft for its Institute Fraunhofer Institute for Molecular Biology and Applied Ecology (IME) | |||||||||||||
Full Title: Randomised, open lable, active controlled clinical trial to demonstrate safety and efficacy of an i.v. administration of Polyglucoferron compared to i.v. Ferric Carboxymaltose and oral iron substit... | |||||||||||||
Medical condition: preoperative iron deficiency anaemia in patients with planned elective non-cardiac surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GB (GB - no longer in EU/EEA) AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-000516-42 | Sponsor Protocol Number: CLX003-IMP-2-170121 | Start Date*: 2018-03-20 | ||||||||||||||||
Sponsor Name:Cell Therapy Ltd (trading as Celixir) | ||||||||||||||||||
Full Title: A Phase IIB, Randomised, Double-Blinded, Placebo-Controlled Study of the Efficacy and Safety of Intramyocardial Injection of Allogeneic Human Immunomodulatory Progenitor (iMP) cells in Patients Und... | ||||||||||||||||||
Medical condition: Ischaemic heart disease post MI | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001056-22 | Sponsor Protocol Number: NDOL-001-2016 | Start Date*: 2016-08-24 |
Sponsor Name:Medical Univerity Vienna | ||
Full Title: Neodolpasse® Infusion Solution versus diclofenac 75 mg infusion in the treatment of postoperative pain after elective knee surgery - an exploratory placebo-controlled clinical study to investigate ... | ||
Medical condition: major elective knee surgery (cruciate ligament surgery) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-018720-12 | Sponsor Protocol Number: pb01 | Start Date*: 2010-04-22 |
Sponsor Name:Swedish Pituitary Study group | ||
Full Title: Behandling med kabergolin hos patienter med ACTH-beroende Cushing´s syndrom (treatment with cabergoline in patients with ACTH-dependent Cushing´s syndrome | ||
Medical condition: A) Men and women aged 18 to 75 years with hypercortisolism due to ACTH-dependent Cushing's syndrome will be treated in the period between diagnosis and planned surgery or radiation therapy. B) Men... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-010173-20 | Sponsor Protocol Number: A3051113 | Start Date*: 2009-08-06 | |||||||||||
Sponsor Name:Pfizer Limited, Ramsgate Road, Sandwich, Kent, CT13 9NJ, UK | |||||||||||||
Full Title: A MULTICENTER, OPEN LABEL STUDY TO INVESTIGATE THE FEASIBILITY AND EFFICACY OF A SMOKING CESSATION PROGRAM WITH VARENICLINE IN PATIENTS UNDERGOING ELECTIVE SURGERY | |||||||||||||
Medical condition: Smoking cessation in patients scheduled for elective surgery. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-003530-13 | Sponsor Protocol Number: 18072011 | Start Date*: 2011-12-20 | |||||||||||
Sponsor Name:Brighton & Sussex University Hospitals NHS Trust | |||||||||||||
Full Title: Randomised phase II window study of short-term preoperative treatment with the PI3K inhibitor GDC-0941 plus Anastrozole versus Anastrozole alone in patients with ER-positive primary breast cancer | |||||||||||||
Medical condition: Primary breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-005200-19 | Sponsor Protocol Number: I-CONIC | Start Date*: 2022-05-09 |
Sponsor Name:Västra Götalandsregionen/Onkologiska kliniken | ||
Full Title: Use of Imatinib to convert triple negative breast cancer into ER-positive breast cancer - "I-CONIC" | ||
Medical condition: Early Triple Negative Breast Cancer planned for surgery. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2016-004744-11 | Sponsor Protocol Number: PERFECT | Start Date*: 2017-02-27 |
Sponsor Name:Academic Medical Center | ||
Full Title: PDL-1 targeting in resectable oesophageal cancer: a phase IB feasibility study of Atezolizumab and chemoradiation (PERFECT) | ||
Medical condition: oesophageal cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-002909-25 | Sponsor Protocol Number: 74310 | Start Date*: 2020-10-21 |
Sponsor Name:Amsterdam University Medical Centers | ||
Full Title: Blood-borne assessment of stromal activation in esophageal adenocarcinoma to guide tocilizumab therapy: a randomized phase II proof-of-concept study | ||
Medical condition: oesophageal adenocarcinoma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-003683-12 | Sponsor Protocol Number: SENTOV | Start Date*: 2018-01-23 | |||||||||||
Sponsor Name:INSTITUTO DE INVESTIGACIÓN SANITARIA LA FE | |||||||||||||
Full Title: Sentinel node in ovarian cáncer: tailoring clinical feasibility | |||||||||||||
Medical condition: Early stage ovarian cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002769-72 | Sponsor Protocol Number: SM1-DHAG-2016 | Start Date*: 2016-08-29 | ||||||||||||||||
Sponsor Name:Næstved Hospital | ||||||||||||||||||
Full Title: DEXRAR: DEXamethasone in Revision ARthroplasty: A randomised, blinded, 2-group clinical trial | ||||||||||||||||||
Medical condition: Pain after revision surgery after total knee replacement | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000134-22 | Sponsor Protocol Number: MDCO-CAN-15-01 | Start Date*: 2021-01-14 |
Sponsor Name:Chiesi Farmaceutici S.p.A. | ||
Full Title: A Prospective, Open-Label, Single-Arm, Multi-Center Study to Assess The Pharmacokinetics/Pharmacodynamics (PK/PD) AND Safety Of Different Cangrelor Doses In Neonatal Subjects At Risk Of Thrombosis. | ||
Medical condition: Postoperative neonatal cardiac subjects who are undergoing surgery for placement of systemic-to pulmonary artery palliative shunts (e.g., Blalock-Taussig or central shunt), right ventricle to pulmo... | ||
Disease: | ||
Population Age: Newborns, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2018-003680-62 | Sponsor Protocol Number: CHIPPI-1808 | Start Date*: 2019-02-06 | |||||||||||||||||||||
Sponsor Name:Centre Oscar Lambret | |||||||||||||||||||||||
Full Title: Phase III randomized clinical trial evaluating hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer considering two different settings: Primary Debulking Surgery (PDS) and Interval D... | |||||||||||||||||||||||
Medical condition: Epithelial ovarian cancer, Fallopian tube ovarian cancer, Peritoneal ovarian cancer | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||||||||||||
Trial protocol: FR (Trial now transitioned) BE (Trial now transitioned) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002996-32 | Sponsor Protocol Number: 12UK/DCsc04 | Start Date*: 2012-11-12 | |||||||||||
Sponsor Name:IBSA Institut Biochimique S.A. | |||||||||||||
Full Title: Preliminary evaluation of the efficacy and local tolerability of Injectable Diclofenac at 5, 12.5, 25 and 50 mg/mL, administered locally prior to surgery for the prevention of post-operative pain a... | |||||||||||||
Medical condition: post-surgical pain after lower third molar removal. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: Removed from public view |
EudraCT Number: 2015-002488-40 | Sponsor Protocol Number: LIPMAT | Start Date*: 2015-11-06 | |||||||||||
Sponsor Name:Leiden University Medical Center | |||||||||||||
Full Title: The LIPMAT study: Liposomal prednisolone to improve hemodialysis fistula maturation | |||||||||||||
Medical condition: Nonmaturation of arteriovenous vascular accesses for hemodialysis. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001200-55 | Sponsor Protocol Number: 564038 | Start Date*: 2015-09-23 |
Sponsor Name:Region Östergötland | ||
Full Title: A single postoperative bisphosphonate infusion to improve patient reported function after hip or knee replacement. | ||
Medical condition: Prosthetic loosening of hip and knee arthroplasty | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-005697-71 | Sponsor Protocol Number: 060402 | Start Date*: 2006-01-26 | |||||||||||
Sponsor Name:Baxalta Innovations GmbH | |||||||||||||
Full Title: Antihemophilic Factor (Recombinant) Plasma/Albumin-Free Method (rAHF PFM): A Phase 3/4, Prospective, Controlled, Randomized, Multi-Center Study to Compare the Efficacy and Safety of Continuous Infu... | |||||||||||||
Medical condition: Subjects with Severe or Moderately Severe Hemophilia A (baseline factor VIII (FVIII) level <= 2% of normal) hemophilia A undergoing major orthopedic surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) SE (Completed) BE (Completed) PT (Completed) ES (Completed) HU (Completed) NL (Completed) GB (Completed) IT (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-001219-35 | Sponsor Protocol Number: COR-2017-01 | Start Date*: 2018-01-22 | |||||||||||
Sponsor Name:Cortendo AB | |||||||||||||
Full Title: A Double-blind, Placebo-Controlled, Randomized Withdrawal Following Open-label Therapy Study to Assess the Safety and Efficacy of Levoketoconazole (2S,4R-ketoconazole) in the Treatment of Endogenou... | |||||||||||||
Medical condition: Endogenous Cushing´s syndrome (CS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) FR (Completed) BG (Completed) HU (Completed) PL (Completed) NL (Completed) DK (Prematurely Ended) GR (Completed) IT (Completed) RO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-000535-33 | Sponsor Protocol Number: BCII_2015 | Start Date*: 2015-12-01 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: Phase II, Open-Label Study to Evaluate Safety and Explore Efficacy of Escalating Doses of Bevacizumab-IRDye800CW as an Optical Imaging Agent to Detect Cancer Tissue Delineation During Tumor Resecti... | ||
Medical condition: Patients with breast cancer eligible for surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
